BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37569786)

  • 1. Effects of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in P301S Mice Modeling Alzheimer's Disease Tauopathies.
    Géraudie A; Riche M; Lestra T; Trotier A; Dupuis L; Mathon B; Carpentier A; Delatour B
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease.
    Lynch M; Heinen S; Markham-Coultes K; O'Reilly M; Van Slyke P; Dumont DJ; Hynynen K; Aubert I
    Int J Med Sci; 2021; 18(2):482-493. PubMed ID: 33390817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
    Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
    Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA
    Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety Profile of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in Non-epileptic Mice and in a Mouse Model of Mesial Temporal Lobe Epilepsy.
    Mathon B; Navarro V; Lecas S; Roussel D; Charpier S; Carpentier A
    Ultrasound Med Biol; 2023 May; 49(5):1327-1336. PubMed ID: 36878831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
    Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
    J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy.
    Bajracharya R; Cruz E; Götz J; Nisbet RM
    J Control Release; 2022 Sep; 349():634-648. PubMed ID: 35901857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer's disease.
    Liu Y; Gong Y; Xie W; Huang A; Yuan X; Zhou H; Zhu X; Chen X; Liu J; Liu J; Qin X
    Nanoscale; 2020 Mar; 12(11):6498-6511. PubMed ID: 32154811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
    Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
    Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
    Rezai AR; Ranjan M; D'Haese PF; Haut MW; Carpenter J; Najib U; Mehta RI; Chazen JL; Zibly Z; Yates JR; Hodder SL; Kaplitt M
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9180-9182. PubMed ID: 32284421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
    Sabbagh A; Beccaria K; Ling X; Marisetty A; Ott M; Caruso H; Barton E; Kong LY; Fang D; Latha K; Zhang DY; Wei J; DeGroot J; Curran MA; Rao G; Hu J; Desseaux C; Bouchoux G; Canney M; Carpentier A; Heimberger AB
    Clin Cancer Res; 2021 Aug; 27(15):4325-4337. PubMed ID: 34031054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice.
    Ruan Z; Delpech JC; Venkatesan Kalavai S; Van Enoo AA; Hu J; Ikezu S; Ikezu T
    Mol Neurodegener; 2020 Aug; 15(1):47. PubMed ID: 32811520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Intermittent Hypoxia Enhances Pathological Tau Seeding, Propagation, and Accumulation and Exacerbates Alzheimer-like Memory and Synaptic Plasticity Deficits and Molecular Signatures.
    Kazim SF; Sharma A; Saroja SR; Seo JH; Larson CS; Ramakrishnan A; Wang M; Blitzer RD; Shen L; Peña CJ; Crary JF; Shimoda LA; Zhang B; Nestler EJ; Pereira AC
    Biol Psychiatry; 2022 Feb; 91(4):346-358. PubMed ID: 34130857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scanning ultrasound in the absence of blood-brain barrier opening is not sufficient to clear β-amyloid plaques in the APP23 mouse model of Alzheimer's disease.
    Leinenga G; Koh WK; Götz J
    Brain Res Bull; 2019 Nov; 153():8-14. PubMed ID: 31400496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions.
    Pandit R; Leinenga G; Götz J
    Theranostics; 2019; 9(13):3754-3767. PubMed ID: 31281511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
    Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
    J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic evaluation of activation of acute inflammatory response in a mouse model following ultrasound-mediated blood-brain barrier using different acoustic pressures and microbubble doses.
    Pascal A; Li N; Lechtenberg KJ; Rosenberg J; Airan RD; James ML; Bouley DM; Pauly KB
    Nanotheranostics; 2020; 4(4):210-223. PubMed ID: 32802731
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.